1.11CAD
27.51 MCAD
28.56 MCAD
12.94 M
About CIPHER PHARMACEUTICALS INC
Sector
CEO
Craig Mull
Headquarters
Mississauga
Website
Founded
2000
ISIN
CA17253X1050
FIGI
BBG000BSKPS7
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Mississauga, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CPH is 8.50 CAD — it has decreased by 3.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange CIPHER PHARMACEUTICALS INC stocks are traded under the ticker CPH.
CIPHER PHARMACEUTICALS INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CPH stock is 6.06% volatile and has beta coefficient of −0.31. Check out the list of the most volatile stocks — is CIPHER PHARMACEUTICALS INC there?
One year price forecast for CIPHER PHARMACEUTICALS INC has a max estimate of 9.26 CAD and a min estimate of 8.01 CAD.
CPH earnings for the last quarter are 0.37 CAD per share, whereas the estimation was 0.10 CAD resulting in a 285.71% surprise. The estimated earnings for the next quarter are 0.13 CAD per share. See more details about CIPHER PHARMACEUTICALS INC earnings.
CIPHER PHARMACEUTICALS INC revenue for the last quarter amounts to 8.24 M CAD despite the estimated figure of 7.13 M CAD. In the next quarter revenue is expected to reach 6.94 M CAD.
Yes, you can track CIPHER PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
CPH stock has fallen by 6.49% compared to the previous week, the month change is a 1.07% rise, over the last year CIPHER PHARMACEUTICALS INC has showed a 151.48% increase.
CPH net income for the last quarter is 10.43 M CAD, while the quarter before that showed 9.43 M CAD of net income which accounts for 10.56% change. Track more CIPHER PHARMACEUTICALS INC financial stats to get the full picture.
Today CIPHER PHARMACEUTICALS INC has the market capitalization of 211.28 M, it has increased by 0.12% over the last week.
No, CPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CIPHER PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CIPHER PHARMACEUTICALS INC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CIPHER PHARMACEUTICALS INC stock shows the buy signal. See more of CIPHER PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CIPHER PHARMACEUTICALS INC future price: according to them, CPH price has a max estimate of 9.26 CAD and a min estimate of 8.01 CAD. Read a more detailed CIPHER PHARMACEUTICALS INC forecast: see what analysts think of CIPHER PHARMACEUTICALS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CIPHER PHARMACEUTICALS INC EBITDA is 15.19 M CAD, and current EBITDA margin is 53.21%. See more stats in CIPHER PHARMACEUTICALS INC financial statements.